Menu
Close
In recent years, the prevalence of tick-borne encephalitis virus (TBEV) has increased, and more endemic areas have been reported.4
TicoVac® offers TBE vaccination based on over two decades of clinical experience in Europe.5,6
Overall field effectiveness in regularly vaccinated persons in Austria having received the primary series was 96–99% for the years 2000–2011.2,6,7
TicoVac® may help protect against the main TBE virus subtypes found in nature.3 Three main subtypes of TBE exist across Europe and Asia: European, Siberian, and Far Eastern.8 It is difficult to know which subtype your patients will come in contact with, so helping to protect against the main subtypes is important.
Tick-borne Encephalitis is a disease caused by a virus that can be spread by a bite from an infected tick or through consumption of unpasteurized dairy products.1